61
https://pubmed.ncbi.nlm.nih.gov/38116406
Scientists have identified and developed a series of allosteric, fragment-sized NIK ligands that bind with micromolar potency and good ligand efficiency, providing a potential alternative approach to targeting NIK for therapeutic purposes.
